Title | Author(s) | Issue date | ???itemlist.??? |
Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort | Athyros, V. G.; Liberopoulos, E. N.; Mikhailidis, D. P.; Papageorgiou, A. A.; Ganotakis, E. S.; Tziomalos, K.; Kakafika, A. I.; Karagiannis, A.; Lambropoulos, S.; Elisaf, M. S. | 24-Nov-2015 | - |
Awareness, treatment and control of the metabolic syndrome and its components: a multicentre Greek study | Athyros, V. G.; Ganotakis, E. S.; Bathianaki, M.; Monedas, I.; Goudevenos, I. A.; Papageorgiou, A. A.; Papathanasiou, A.; Kakafika, A. I.; Mikhailidis, D. P.; Elisaf, M. S. | 24-Nov-2015 | - |
Dyslipidaemia, hypercoagulability and the metabolic syndrome | Kakafika, A. I.; Liberopoulos, E. N.; Karagiannis, A.; Athyros, V. G.; Mikhailidis, D. P. | 24-Nov-2015 | - |
The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate | Christidis, D. S.; Liberopoulos, E. N.; Kakafika, A. I.; Miltiadous, G. A.; Cariolou, M.; Ganotakis, E. S.; Mikhailidis, D. P.; Elisaf, M. S. | 24-Nov-2015 | - |
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study | Athyros, V. G.; Mikhailidis, D. P.; Didangelos, T. P.; Giouleme, O. I.; Liberopoulos, E. N.; Karagiannis, A.; Kakafika, A. I.; Tziomalos, K.; Burroughs, A. K.; Elisaf, M. S. | 24-Nov-2015 | - |
Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin | Christidis, D. S.; Liberopoulos, E. N.; Kakafika, A. I.; Miltiadous, G. A.; Liamis, G. L.; Kakaidi, B.; Tselepis, A. D.; Cariolou, M. A.; Elisaf, M. S. | 24-Nov-2015 | - |
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study | Athyros, V. G.; Mikhailidis, D. P.; Liberopoulos, E. N.; Kakafika, A. I.; Karagiannis, A.; Papageorgiou, A. A.; Tziomalos, K.; Ganotakis, E. S.; Elisaf, M. S. | 24-Nov-2015 | - |
Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study | Athyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Bouloukos, V. I.; Pehlivanidis, A. N.; Symeonidis, A. N.; Kakafika, A. I.; Daskalopoulou, S. S.; Elisaf, M. S. | 24-Nov-2015 | - |
Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia | Milionis, H. J.; Kakafika, A. I.; Tsouli, S. G.; Athyros, V. G.; Bairaktari, E. T.; Seferiadis, K. I.; Elisaf, M. S. | 24-Nov-2015 | - |
Fibrinogen: a predictor of vascular disease | Kakafika, A. I.; Liberopoulos, E. N.; Mikhailidis, D. P. | 24-Nov-2015 | - |
Hypouricemia in individuals admitted to an inpatient hospital-based facility | Bairaktari, E. T.; Kakafika, A. I.; Pritsivelis, N.; Hatzidimou, K. G.; Tsianos, E. V.; Seferiadis, K. I.; Elisaf, M. S. | 24-Nov-2015 | - |
Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels | Athyros, V. G.; Mikhailidis, D. P.; Kakafika, A. I.; Karagiannis, A.; Hatzitolios, A.; Tziomalos, K.; Ganotakis, E. S.; Liberopoulos, E. N.; Elisaf, M. S. | 24-Nov-2015 | - |
The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity | Kakafika, A. I.; Xenofontos, S.; Tsimihodimos, V.; Tambaki, A. P.; Lourida, E. S.; Kalaitzidis, R.; Cariolou, M. A.; Elisaf, M.; Tselepis, A. D. | 24-Nov-2015 | - |
Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study | Athyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Didangelos, T. P.; Ganotakis, E. S.; Symeonidis, A. N.; Daskalopoulou, S. S.; Kakafika, A. I.; Elisaf, M. S. | 24-Nov-2015 | - |
The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal? | Karagiannis, A.; Mikhailidis, D. P.; Athyros, V. G.; Kakafika, A. I.; Tziomalos, K.; Liberopoulos, E. N.; Florentin, M.; Elisaf, M. S. | 24-Nov-2015 | - |
Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients | Athyros, V. G.; Kakafika, A. I.; Papageorgiou, A. A.; Pagourelias, E. D.; Savvatianos, S. D.; Elisaf, M. S.; Karagiannis, A.; Tziomalos, K.; Mikhailidis, D. P. | 24-Nov-2015 | - |
Targeting vascular risk in patients with metabolic syndrome but without diabetes | Athyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Didangelos, T. P.; Peletidou, A.; Kleta, D.; Karagiannis, A.; Kakafika, A. I.; Tziomalos, K.; Elisaf, M. S. | 24-Nov-2015 | - |